PWM
AMED

Parkworth Wealth Management’s Amedisys AMED Stock Holding History

Parkworth Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$394 Buy
4
+3
+300% +$284 ﹤0.01% 711
2025
Q1 		$93 Hold
1
– – ﹤0.01% 958
2024
Q4 		$91 Buy
+1
New +$92 ﹤0.01% 1007

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Parkworth Wealth Management's AMED Position: Q2 2025 in Review

Parkworth Wealth Management increased its Amedisys (AMED) stake by 300% in Q2 2025, buying an estimated $284 and bringing the position to 4 shares worth $394. The position accounts for ﹤0.01% of the portfolio, ranked #711.

Parkworth Wealth Management first reported a position in AMED in Q4 2024 and has held it in 3 quarters since. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Parkworth Wealth Management held 4 shares of Amedisys worth $394 as of Q2 2025.
  • Parkworth Wealth Management bought 3 Amedisys shares in Q2 2025, an estimated $284.
  • Amedisys made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #711 holding.
  • Parkworth Wealth Management first reported a position in Amedisys in Q4 2024 and has held it in 3 quarters since.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.